The value of observational registry studies for the next infectious disease emergency-Reference-Cited by-同舟云学术

The value of observational registry studies for the next infectious disease emergency

Published:2023-12-19 Issue:6 Volume:14 Page:
ISSN:2150-7511
Container-title:mBio
language:en
Short-container-title:mBio

Author:

Senefeld Jonathon W.¹^ORCID,Marks Peter²,Casadevall Arturo³^ORCID,Joyner Michael J.⁴

Affiliation:

1. Department of Kinesiology and Community Health, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA

2. Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA

3. Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA

4. Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, USA

Abstract

ABSTRACT During infectious disease emergencies, it may be necessary to deploy new therapies without conclusive evidence for their effectiveness. During the SARS-CoV-2 pandemic, several countries used registries to track the use of COVID-19 convalescent plasma (CCP). Those registries provided evidence that CCP was effective when used early and with high titer.

Publisher

American Society for Microbiology

Subject

Virology,Microbiology

Link

https://journals.asm.org/doi/pdf/10.1128/mbio.02565-23

Reference26 articles.

1. Approaches to Continuing COVID-19–Related Clinical Research Practices After the Pandemic—Must Cinderella Leave the Ball?

2. Emerging Lessons From COVID-19 for the US Clinical Research Enterprise

3. How COVID-19 has fundamentally changed clinical research in global health

4. Factors associated with mortality among hospitalized patients with COVID-19 disease treated with convalescent plasma

5. Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Applying lessons of COVID-19 and other emerging infectious diseases to future outbreaks;mBio;2024-06-12

2. Estimates of Actual and Potential Lives Saved in the United States from the use of COVID-19 Convalescent Plasma;2024-05-18

3. Convalescent Plasma and the US Expanded Access Program: A Personal Narrative;Current Topics in Microbiology and Immunology;2024